These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 3225770)

  • 1. Effect of pH on the in vitro dissolution and in vivo absorption of controlled-release theophylline in dogs.
    Vashi VI; Meyer MC
    J Pharm Sci; 1988 Sep; 77(9):760-4. PubMed ID: 3225770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of gastric pH on the absorption of controlled-release theophylline dosage forms in humans.
    Meyer MC; Straughn AB; Jarvi EJ; Wood GC; Vashi VI; Hepp P; Hunt J
    Pharm Res; 1993 Jul; 10(7):1037-45. PubMed ID: 8378245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of raising gastric pH with ranitidine on the absorption and elimination of theophylline from a sustained-release theophylline tablet.
    Betlach CJ; Straughn AB; Meyer MC; Bialer M; Vashi VI; Liebermann P; González MA
    Pharm Res; 1991 Dec; 8(12):1516-9. PubMed ID: 1808616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eudraginated polymer blends: a potential oral controlled drug delivery system for theophylline.
    Emeje M; John-Africa L; Isimi Y; Kunle O; Ofoefule S
    Acta Pharm; 2012 Mar; 62(1):71-82. PubMed ID: 22472450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Per-oral controlled release dosage form of theophylline using soybean protein.
    Machida Y; Tokumura T; Nagai T
    Drug Des Deliv; 1987 Feb; 1(3):187-92. PubMed ID: 3509332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissolution of theophylline from film-coated slow release mini-tablets in various dissolution media.
    Fassihi AR; Munday DL
    J Pharm Pharmacol; 1989 Jun; 41(6):369-72. PubMed ID: 2570830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sustained-release effect of the direct compressed tablet based on chitosan and Na alginate].
    Yomota C; Miyazaki T; Okada S
    Yakugaku Zasshi; 1994 Apr; 114(4):257-63. PubMed ID: 8201547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissolution of theophylline from sustained-release dosage forms and correlation with saliva bioavailability parameters.
    Chung BH; Shim CK
    J Pharm Sci; 1987 Oct; 76(10):784-7. PubMed ID: 3430341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Release and absorption characteristics of novel theophylline sustained-release formulations: in vitro-in vivo correlation.
    Hussein Z; Friedman M
    Pharm Res; 1990 Nov; 7(11):1167-71. PubMed ID: 2293217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the bioavailability and pharmacokinetics of two extended-release theophylline formulations in dogs.
    Bach JE; Kukanich B; Papich MG; McKiernan BC
    J Am Vet Med Assoc; 2004 Apr; 224(7):1113-9. PubMed ID: 15074856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vitro-In Vivo Predictive Dissolution-Permeation-Absorption Dynamics of Highly Permeable Drug Extended-Release Tablets via Drug Dissolution/Absorption Simulating System and pH Alteration.
    Li ZQ; Tian S; Gu H; Wu ZG; Nyagblordzro M; Feng G; He X
    AAPS PharmSciTech; 2018 May; 19(4):1882-1893. PubMed ID: 29663288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
    Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
    Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of pretreatment with ranitidine on the pharmacokinetics and gastrointestinal transit of a sustained-release theophylline preparation].
    Wilson CG; Washington N; Greaves JL; Blackshaw PE; Perkins AC; Barkworth MF; Rehm KD
    Arzneimittelforschung; 1998 May; 48(5A):561-8. PubMed ID: 9676345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo-in vitro correlations with sustained-release theophylline preparations.
    Ritschel WA; Koch HP; Alcorn GJ
    Methods Find Exp Clin Pharmacol; 1984 Oct; 6(10):609-18. PubMed ID: 6513678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of in vivo drug release behavior of controlled-release multiple-unit dosage forms in dogs using a flow-through type dissolution test method.
    Ikegami K; Tagawa K; Kobayashi M; Osawa T
    Int J Pharm; 2003 Jun; 258(1-2):31-43. PubMed ID: 12753751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the absorption of theophylline from immediate- and controlled-release dosage forms with a numerical approach using the in vitro dissolution-permeation process using caco-2 cells.
    Noureddine N; Zerrouk N; Nicolis I; Allain P; Sfar S; Chaumeil JC
    Drug Dev Ind Pharm; 2005 May; 31(4-5):397-404. PubMed ID: 16093205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pretreatment with ranitidine on the pharmacokinetics and gastrointestinal transit of a sustained release theophylline preparation.
    Wilson CG; Washington N; Greaves JL; Blackshaw PE; Perkins AC; Barkworth MF; Rehm KD
    Arzneimittelforschung; 1991 Nov; 41(11):1154-9. PubMed ID: 1810260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of gastrointestinal physiology regulated-dogs: bioavailability study of a commercial sustained-release dosage form of theophylline.
    Sagara K; Kawata M; Mizuta H; Shibata M
    Biol Pharm Bull; 1994 Jul; 17(7):931-4. PubMed ID: 8000380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro-in vivo correlation and dissolution studies with oral theophylline dosage forms.
    el-Yazigi A; Sawchuk RJ
    J Pharm Sci; 1985 Feb; 74(2):161-4. PubMed ID: 3989685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.